APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Soft Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Enzalutamide Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchEnzalutamide Soft Capsules Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Soft Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Enzalutamide Soft Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Soft Capsules Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Soft Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Enzalutamide Soft Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Enzalutamide Soft Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enzalutamide Soft Capsules include Aprazer Healthcare Pharma, Arechar Healthcare, Astellas Pharma, BDR Pharma, Glenmark Pharma, Intas Pharmaceuticals, Pfizer, Jiangsu Hansoh Pharmaceutical and Kelun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enzalutamide Soft Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enzalutamide Soft Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enzalutamide Soft Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enzalutamide Soft Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Enzalutamide Soft Capsules Segment by Company

Aprazer Healthcare Pharma

Arechar Healthcare

Astellas Pharma

BDR Pharma

Glenmark Pharma

Intas Pharmaceuticals

Pfizer

Jiangsu Hansoh Pharmaceutical

Kelun Pharmaceutical

Qilu Pharmaceutical

PuraCap Pharmaceuticals

Shenyang Hongqi Pharmaceutical

Yichang Humanwell Pharmaceutical

Enzalutamide Soft Capsules Segment by Type

Original Drug

Generic Drug

Enzalutamide Soft Capsules Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Enzalutamide Soft Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Soft Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Soft Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Soft Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enzalutamide Soft Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzalutamide Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Enzalutamide Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Enzalutamide Soft Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Enzalutamide Soft Capsules Industry Trends Table 2. Enzalutamide Soft Capsules Industry Drivers Table 3. Enzalutamide Soft Capsules Industry Opportunities and Challenges Table 4. Enzalutamide Soft Capsules Industry Restraints Table 5. Global Enzalutamide Soft Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Enzalutamide Soft Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Enzalutamide Soft Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Enzalutamide Soft Capsules Sales Market Share by Manufacturers Table 9. Global Enzalutamide Soft Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Enzalutamide Soft Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Enzalutamide Soft Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Enzalutamide Soft Capsules Manufacturers, Product Type & Application Table 13. Global Enzalutamide Soft Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Enzalutamide Soft Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Original Drug Table 17. Major Manufacturers of Generic Drug Table 18. Global Enzalutamide Soft Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Enzalutamide Soft Capsules Sales by Type (2021-2026) & (K Units) Table 20. Global Enzalutamide Soft Capsules Sales by Type (2027-2032) & (K Units) Table 21. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2026) Table 22. Global Enzalutamide Soft Capsules Sales Market Share by Type (2027-2032) Table 23. Global Enzalutamide Soft Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Enzalutamide Soft Capsules Revenue by Type (2021-2026) & (K Units) Table 25. Global Enzalutamide Soft Capsules Revenue by Type (2027-2032) & (K Units) Table 26. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2026) Table 27. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital and Clinic Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Other Table 31. Global Enzalutamide Soft Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Enzalutamide Soft Capsules Sales by Application (2021-2026) & (K Units) Table 33. Global Enzalutamide Soft Capsules Sales by Application (2027-2032) & (K Units) Table 34. Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2026) Table 35. Global Enzalutamide Soft Capsules Sales Market Share by Application (2027-2032) Table 36. Global Enzalutamide Soft Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Enzalutamide Soft Capsules Revenue by Application (2021-2026) & (K Units) Table 38. Global Enzalutamide Soft Capsules Revenue by Application (2027-2032) & (K Units) Table 39. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2026) Table 40. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2027-2032) Table 41. Global Enzalutamide Soft Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Enzalutamide Soft Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Enzalutamide Soft Capsules Sales Market Share by Region (2021-2026) Table 44. Global Enzalutamide Soft Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Enzalutamide Soft Capsules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 48. North America Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 49. Europe Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 51. Europe Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2027-2032) & (K Units) Table 58. Global Enzalutamide Soft Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Enzalutamide Soft Capsules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Enzalutamide Soft Capsules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2026) Table 62. Global Enzalutamide Soft Capsules Revenue Market Share by Region (2027-2032) Table 63. Aprazer Healthcare Pharma Company Information Table 64. Aprazer Healthcare Pharma Business Overview Table 65. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio Table 67. Aprazer Healthcare Pharma Recent Development Table 68. Arechar Healthcare Company Information Table 69. Arechar Healthcare Business Overview Table 70. Arechar Healthcare Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio Table 72. Arechar Healthcare Recent Development Table 73. Astellas Pharma Company Information Table 74. Astellas Pharma Business Overview Table 75. Astellas Pharma Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Astellas Pharma Enzalutamide Soft Capsules Product Portfolio Table 77. Astellas Pharma Recent Development Table 78. BDR Pharma Company Information Table 79. BDR Pharma Business Overview Table 80. BDR Pharma Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BDR Pharma Enzalutamide Soft Capsules Product Portfolio Table 82. BDR Pharma Recent Development Table 83. Glenmark Pharma Company Information Table 84. Glenmark Pharma Business Overview Table 85. Glenmark Pharma Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio Table 87. Glenmark Pharma Recent Development Table 88. Intas Pharmaceuticals Company Information Table 89. Intas Pharmaceuticals Business Overview Table 90. Intas Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 92. Intas Pharmaceuticals Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Enzalutamide Soft Capsules Product Portfolio Table 97. Pfizer Recent Development Table 98. Jiangsu Hansoh Pharmaceutical Company Information Table 99. Jiangsu Hansoh Pharmaceutical Business Overview Table 100. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 102. Jiangsu Hansoh Pharmaceutical Recent Development Table 103. Kelun Pharmaceutical Company Information Table 104. Kelun Pharmaceutical Business Overview Table 105. Kelun Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 107. Kelun Pharmaceutical Recent Development Table 108. Qilu Pharmaceutical Company Information Table 109. Qilu Pharmaceutical Business Overview Table 110. Qilu Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 112. Qilu Pharmaceutical Recent Development Table 113. PuraCap Pharmaceuticals Company Information Table 114. PuraCap Pharmaceuticals Business Overview Table 115. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio Table 117. PuraCap Pharmaceuticals Recent Development Table 118. Shenyang Hongqi Pharmaceutical Company Information Table 119. Shenyang Hongqi Pharmaceutical Business Overview Table 120. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 122. Shenyang Hongqi Pharmaceutical Recent Development Table 123. Yichang Humanwell Pharmaceutical Company Information Table 124. Yichang Humanwell Pharmaceutical Business Overview Table 125. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio Table 127. Yichang Humanwell Pharmaceutical Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Enzalutamide Soft Capsules Distributors List Table 131. Enzalutamide Soft Capsules Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Enzalutamide Soft Capsules Product Image Figure 2. Global Enzalutamide Soft Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Soft Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzalutamide Soft Capsules Sales (2021-2032) & (K Units) Figure 5. Global Enzalutamide Soft Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Enzalutamide Soft Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Original Drug Image Figure 9. Generic Drug Image Figure 10. Global Enzalutamide Soft Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Enzalutamide Soft Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2032) Figure 13. Global Enzalutamide Soft Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Enzalutamide Soft Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2032) Figure 16. Hospital and Clinic Image Figure 17. Retail Pharmacies Image Figure 18. Other Image Figure 19. Global Enzalutamide Soft Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Enzalutamide Soft Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2032) Figure 22. Global Enzalutamide Soft Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Enzalutamide Soft Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2032) Figure 25. North America Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Enzalutamide Soft Capsules Sales Market Share by Country (2021-2032) Figure 27. U.S. Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Enzalutamide Soft Capsules Sales Market Share by Country (2021-2032) Figure 32. Germany Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Enzalutamide Soft Capsules Sales Market Share by Country (2021-2032) Figure 39. China Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Enzalutamide Soft Capsules Sales Market Share by Country (2021-2032) Figure 47. Brazil Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Enzalutamide Soft Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Enzalutamide Soft Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Enzalutamide Soft Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Figure 58. North America Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Enzalutamide Soft Capsules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Enzalutamide Soft Capsules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Enzalutamide Soft Capsules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Aprazer Healthcare Pharma
  • Arechar Healthcare
  • Astellas Pharma
  • BDR Pharma
  • Glenmark Pharma
  • Intas Pharmaceuticals
  • Pfizer
  • Jiangsu Hansoh Pharmaceutical
  • Kelun Pharmaceutical
  • Qilu Pharmaceutical
  • PuraCap Pharmaceuticals
  • Shenyang Hongqi Pharmaceutical
  • Yichang Humanwell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enzalutamide Soft Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enzalutamide Soft Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Enzalutamide Soft Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Enzalutamide Soft Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Enzalutamide Soft Capsules Market Dynamics
  1. 2.1 Enzalutamide Soft Capsules Industry Trends
  2. 2.2 Enzalutamide Soft Capsules Industry Drivers
  3. 2.3 Enzalutamide Soft Capsules Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Soft Capsules Industry Restraints
3 Enzalutamide Soft Capsules Market by Manufacturers
  1. 3.1 Global Enzalutamide Soft Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Enzalutamide Soft Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Enzalutamide Soft Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Enzalutamide Soft Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzalutamide Soft Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Enzalutamide Soft Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Enzalutamide Soft Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzalutamide Soft Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzalutamide Soft Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzalutamide Soft Capsules Tier 1, Tier 2, and Tier 3
4 Enzalutamide Soft Capsules Market by Type
  1. 4.1 Enzalutamide Soft Capsules Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Enzalutamide Soft Capsules Sales by Type
  5. 4.2.1 Global Enzalutamide Soft Capsules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Enzalutamide Soft Capsules Sales by Type (2021-2032)
  7. 4.2.3 Global Enzalutamide Soft Capsules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Enzalutamide Soft Capsules Revenue by Type
  9. 4.3.1 Global Enzalutamide Soft Capsules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Enzalutamide Soft Capsules Revenue by Type (2021-2032)
  11. 4.3.3 Global Enzalutamide Soft Capsules Revenue Market Share by Type (2021-2032)
5 Enzalutamide Soft Capsules Market by Application
  1. 5.1 Enzalutamide Soft Capsules Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Enzalutamide Soft Capsules Sales by Application
  6. 5.2.1 Global Enzalutamide Soft Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enzalutamide Soft Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Enzalutamide Soft Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Enzalutamide Soft Capsules Revenue by Application
  10. 5.3.1 Global Enzalutamide Soft Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Enzalutamide Soft Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Enzalutamide Soft Capsules Revenue Market Share by Application (2021-2032)
6 Global Enzalutamide Soft Capsules Sales by Region
  1. 6.1 Global Enzalutamide Soft Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enzalutamide Soft Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Enzalutamide Soft Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Enzalutamide Soft Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Enzalutamide Soft Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Enzalutamide Soft Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Enzalutamide Soft Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Enzalutamide Soft Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Enzalutamide Soft Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Enzalutamide Soft Capsules Revenue by Region
  1. 7.1 Global Enzalutamide Soft Capsules Revenue by Region
  2. 7.1.1 Global Enzalutamide Soft Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Enzalutamide Soft Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Enzalutamide Soft Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Enzalutamide Soft Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Enzalutamide Soft Capsules Revenue (2021-2032)
  8. 7.2.2 North America Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Enzalutamide Soft Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Enzalutamide Soft Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Enzalutamide Soft Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Enzalutamide Soft Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aprazer Healthcare Pharma
  2. 8.1.1 Aprazer Healthcare Pharma Company Information
  3. 8.1.2 Aprazer Healthcare Pharma Business Overview
  4. 8.1.3 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aprazer Healthcare Pharma Enzalutamide Soft Capsules Product Portfolio
  6. 8.1.5 Aprazer Healthcare Pharma Recent Developments
  7. 8.2 Arechar Healthcare
  8. 8.2.1 Arechar Healthcare Company Information
  9. 8.2.2 Arechar Healthcare Business Overview
  10. 8.2.3 Arechar Healthcare Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arechar Healthcare Enzalutamide Soft Capsules Product Portfolio
  12. 8.2.5 Arechar Healthcare Recent Developments
  13. 8.3 Astellas Pharma
  14. 8.3.1 Astellas Pharma Company Information
  15. 8.3.2 Astellas Pharma Business Overview
  16. 8.3.3 Astellas Pharma Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Astellas Pharma Enzalutamide Soft Capsules Product Portfolio
  18. 8.3.5 Astellas Pharma Recent Developments
  19. 8.4 BDR Pharma
  20. 8.4.1 BDR Pharma Company Information
  21. 8.4.2 BDR Pharma Business Overview
  22. 8.4.3 BDR Pharma Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BDR Pharma Enzalutamide Soft Capsules Product Portfolio
  24. 8.4.5 BDR Pharma Recent Developments
  25. 8.5 Glenmark Pharma
  26. 8.5.1 Glenmark Pharma Company Information
  27. 8.5.2 Glenmark Pharma Business Overview
  28. 8.5.3 Glenmark Pharma Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Pharma Enzalutamide Soft Capsules Product Portfolio
  30. 8.5.5 Glenmark Pharma Recent Developments
  31. 8.6 Intas Pharmaceuticals
  32. 8.6.1 Intas Pharmaceuticals Company Information
  33. 8.6.2 Intas Pharmaceuticals Business Overview
  34. 8.6.3 Intas Pharmaceuticals Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intas Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  36. 8.6.5 Intas Pharmaceuticals Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Enzalutamide Soft Capsules Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Jiangsu Hansoh Pharmaceutical
  44. 8.8.1 Jiangsu Hansoh Pharmaceutical Company Information
  45. 8.8.2 Jiangsu Hansoh Pharmaceutical Business Overview
  46. 8.8.3 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Hansoh Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  48. 8.8.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  49. 8.9 Kelun Pharmaceutical
  50. 8.9.1 Kelun Pharmaceutical Company Information
  51. 8.9.2 Kelun Pharmaceutical Business Overview
  52. 8.9.3 Kelun Pharmaceutical Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kelun Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  54. 8.9.5 Kelun Pharmaceutical Recent Developments
  55. 8.10 Qilu Pharmaceutical
  56. 8.10.1 Qilu Pharmaceutical Company Information
  57. 8.10.2 Qilu Pharmaceutical Business Overview
  58. 8.10.3 Qilu Pharmaceutical Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Qilu Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  60. 8.10.5 Qilu Pharmaceutical Recent Developments
  61. 8.11 PuraCap Pharmaceuticals
  62. 8.11.1 PuraCap Pharmaceuticals Company Information
  63. 8.11.2 PuraCap Pharmaceuticals Business Overview
  64. 8.11.3 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 PuraCap Pharmaceuticals Enzalutamide Soft Capsules Product Portfolio
  66. 8.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 8.12 Shenyang Hongqi Pharmaceutical
  68. 8.12.1 Shenyang Hongqi Pharmaceutical Company Information
  69. 8.12.2 Shenyang Hongqi Pharmaceutical Business Overview
  70. 8.12.3 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shenyang Hongqi Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  72. 8.12.5 Shenyang Hongqi Pharmaceutical Recent Developments
  73. 8.13 Yichang Humanwell Pharmaceutical
  74. 8.13.1 Yichang Humanwell Pharmaceutical Company Information
  75. 8.13.2 Yichang Humanwell Pharmaceutical Business Overview
  76. 8.13.3 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Yichang Humanwell Pharmaceutical Enzalutamide Soft Capsules Product Portfolio
  78. 8.13.5 Yichang Humanwell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enzalutamide Soft Capsules Value Chain Analysis
  2. 9.1.1 Enzalutamide Soft Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enzalutamide Soft Capsules Production Mode & Process
  6. 9.2 Enzalutamide Soft Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enzalutamide Soft Capsules Distributors
  9. 9.2.3 Enzalutamide Soft Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst